More Effective Treatment with Precise Measurements
The economic burden of heart failure is enormous and rising. According to the American Heart Association, heart failure today costs Americans about $30 billion dollars per year, with those costs expected to rise to almost $70 billion by 2030. About 80% of those costs are due to hospitalization.
The front-line therapy to treat heart failure patients with fluid overload is to decongest them via diuresis. The challenge for physicians is determining the dosage of the drug to achieve optimum fluid removal without putting the patient into distress – WITHOUT accurate volume measurement before, during and after treatment.
An accurate and quantitative measurement of volume status gives physicians the potential to improve therapeutic timing and delivery and potentially decrease the chances for complications and days in the hospital.
